Our data suggest that IFN may induce the expansion of memory PR1-CTL with self-renewing capacity in a subset of patients in unmaintained CCR, which may be critical for effective long-term immunity to CML, thereby sustaining CCR in CML patients after IFN withdrawal. Here, TMEM37 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.